Notice of Change to Foreign Component Eligibility in RFA-OD-24-014 "Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)"
Notice Number:
NOT-AT-24-040

Key Dates

Release Date:

April 12, 2024

Related Announcements

  • March 14, 2024 - Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required). See NOFO RFA-OD-24-014

Issued by

National Center for Complementary and Integrative Health (NCCIH)

All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. The following NIH Offices may co-fund applications assigned to those Institutes/Centers.

Office of Dietary Supplements (ODS)

Purpose


The purpose of this Notice is to clarify the Foreign Component Eligibility in the following notice of funding opportunity (NOFO) to allow for Foreign components, as defined in the NIH Grants Policy Statement:

RFA-OD-24-014 - Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)

  

Section III.1 Eligible Applicants, Eligible Organizations, Foreign Institutions subsection has been updated to reflect this change:

Currently Reads:
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Modified to Read (change shown in bold italics):
Foreign Institutions
Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries to:

Barbara C. Sorkin, Ph.D.
Co-Director, CARBON
Office of Dietary Supplements (ODS)
Email: [email protected]